Background and Objective: Aging is associated with increased prevalence of arterial stiffness and hypertension. The senescence-accelerated mouse (SAMP1) demonstrates early and spontaneous aging phenotypes around 6-8 months of age. In contrast, microRNA-150 knockout (miR-150 KO) slows down the aging process and extends lifespan in mice by 20-30%. The object of this study is to investigate whether transplantation of bone marrow cells (BMCs) from miR-150 KO mice attenuates arterial stiffening and hypertension in SAMP1 mice. Method and Results: Pulse wave velocity (PWV) and blood pressure (BP) levels were increased significantly in the SAMP1 mice compared with the age-matched control (AKR/J) mice (10 months), indicating that SAMP1 mice developed arterial stiffening and hypertension. Interestingly, transplantation of bone marrow cells (BMCs) from miR-150-KO mice decreased PWV and BP in SAMP1 mice to nearly control levels within 3 months. BMC transplantation decreased expression of collagen1, TGFβ1, Scleraxis (collagen gene transcription factor), MMP-2 and MMP-9 but increased expression of elastin in aortas of SAMP1 mice, indicating improved arterial remodeling. BMC transplantation from miR-150-KO mice partially rescued the downregulation of B cells lymphocytes and increased the serum level of IgG and IgM, abolished infiltration of T cells and macrophages, and decreased inflammatory cytokine expression in aortas in SAMP1 mice. In the cell culture study, IgG deficiency increased inflammatory factor cytokine expression in endothelial cells, which can be abolished by addition of IgG protein. Conclusion: BMC transplantation from miR-150-KO mice reversed arterial stiffness and hypertension in SAMP1 mice likely via modulation of the immune function. This study demonstrates, for the first time, that BMC transplantation may be an effective therapeutic strategy for aging-related arterial stiffness and hypertension.
Read full abstract